RXRX
Recursion Pharmaceuticals, Inc.
A Salt Lake City company that uses artificial intelligence and automated labs to speed up drug discovery, treating biology like a data problem rather than relying on chance. It was spun out of the University of Utah in 2013 by founders including an MD/PhD student, and its name comes from computer-science "recursion" — the self-improving loop where experimental data trains its AI, which then guides the next experiments. In early tests, its computer-selected drug candidates barely overlapped with ones picked by humans, turning up promising hits that people had missed.
CUSIP: 75629V104HealthcareUS4 holders
Total Value
$270.47M
Total Shares
75.66M
Net Share Change
+3.09M
Activity
4 buying
Investor
Value
Shares
Weight
Change
